Fitzpatrick, Christopher; Floyd, Katherine - In: PharmacoEconomics 30 (2012) 1, pp. 63-80
Background: Around 0.4 million cases of multidrug-resistant tuberculosis (MDR-TB) occur each year. Only a small fraction of these cases are treated according to international guidelines. Evidence relevant to decisions about whether to scale-up treatment for MDR-TB includes cost and...